mitomycin has been researched along with arginyl-glycyl-aspartic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emiroğlu, L; Güler, C; Ilker, SS; Kaynak, S; Kurt, E; Ozer, E; Oztürk, F | 1 |
| Cai, P; He, C; Prasad, P; Rauth, AM; Shan, D; Wu, XY; Zhang, T | 1 |
| Cai, P; He, C; Henderson, JT; Lip, H; Rauth, AM; Wang, Z; Wu, XY; Zhang, T | 1 |
3 other study(ies) available for mitomycin and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents.
Topics: Animals; Cataract; Dexamethasone; Diclofenac; Drug Therapy, Combination; Edetic Acid; Epithelial Cells; Lens Capsule, Crystalline; Mitomycin; Oligopeptides; Phacoemulsification; Rabbits | 2001 |
Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Mitomycin; Molecular Structure; Nanoparticles; Oligopeptides; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2017 |
Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood-Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor-Associated Macrophages.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Doxorubicin; Drug Delivery Systems; Drug Synergism; Female; Humans; Lipids; Macrophages; Mice; Mitomycin; Nanoparticles; Oligopeptides; RAW 264.7 Cells; Receptors, LDL; Survival Analysis; Tissue Distribution; Triple Negative Breast Neoplasms | 2019 |